One of the Khavinson short "bioregulator" peptides (a family that also includes Cartalax, Vilon, Thymogen, Ovagen, Chonluten, Vesugen and others) marketed for tissue-specific effects. Evidence is sparse and largely from a single research tradition.
Pinealon is a three-amino-acid peptide from the same Russian 'bioregulator' family as Epitalon (which also includes Cartalax, Vilon, Thymogen, Ovagen, and others), promoted for brain-protective effects.
The family shares a single proposed mechanism: that these very short peptides enter cells, bind DNA, and switch specific tissue genes on or off. For Pinealon specifically the claimed benefit is neuroprotection.
As with the rest of the family, the evidence is sparse and low-quality and the mechanism isn't independently established — so this is best read as a research curiosity rather than a validated therapeutic.
Searching the published record…
Searching the published record…
Searching the published record…
Studies are surfaced live from the U.S. National Library of Medicine (PubMed). biohackr indexes and links the published record; it does not host or alter source articles.